SFGP
GSK icon

Stonebridge Financial Group (Pennsylvania)’s GSK GSK Stock Holding History

Stonebridge Financial Group (Pennsylvania)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-413
Closed -$16K – 507
2025
Q1 		$16K Hold
413
– – ﹤0.01% 531
2024
Q4 		$14K Buy
+413
New +$14.9K ﹤0.01% 549

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Stonebridge Financial Group (Pennsylvania)'s GSK Position: Q2 2025 in Review

Stonebridge Financial Group (Pennsylvania) sold out of GSK (GSK) in Q2 2025, closing a stake of 413 shares — an estimated $16K sold.

Stonebridge Financial Group (Pennsylvania) first reported a position in GSK in Q4 2024 and held it in 2 quarters. The position peaked at $16K in Q1 2025. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

  • Stonebridge Financial Group (Pennsylvania) reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
  • Stonebridge Financial Group (Pennsylvania) sold 413 GSK shares in Q2 2025, an estimated $16K.
  • Stonebridge Financial Group (Pennsylvania) first reported a position in GSK in Q4 2024 and held it in 2 quarters.
  • Stonebridge Financial Group (Pennsylvania)'s GSK position peaked at $16K in Q1 2025.
  • 890 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Stonebridge Financial Group (Pennsylvania)'s 13F filing for Q2 2025, filed 24 Jul 2025.